Table 1:
Patient Characteristic (n=48) | Frequency (percent) | ||
---|---|---|---|
Sex (female) | 27 (56%) | ||
Median (IQR) | Mean (SD) | Range | |
Age (years) | 49.5 (36, 63) | 50.6 (20) | 19 – 88 |
Income (USD) | $58,049 ($46703, $78,197) | $61,554 ($23,193) | $17,667-$113,542 |
Number of visits per patient | 10 (6, 13) | 10.6 (5.9) | 3 – 27 |
Length of treatment per patient* (days) | 54 (20, 110) | 90 (96.5) | 9 – 373 |
Number of unique medications | 5 (3, 6) | 5.2 (2.6) | 1 – 14 |
Cumulative medication doses | 587 (227, 1052) | 837.2 (850.1) | 48 – 4149 |
Maximum daily dose | 48 (20,51) | 39.6 (20.2) | 6–96 |
Average doses per day | 8.2 (5.8–12.9) | 10.6 (8.0) | 2.7–52.7 |
Number of bottles of medications prescribed per patient | 7 (4, 12) | 10.5 (11.2) | 1 – 49 |
Wholesale price per patient (USD) | $933 ($457, $1422) | $1344 ($1607) | $10 - $8232 |
IQR, interquartile range; SD, standard deviation; USD, United States dollars
length of treatment defined as length on medications until corneal scar formation